Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-12.98M.
ENTERPRISE VALUE (EV)
$-12.98M
Passage Bio, Inc.
Market Cap
$12.88M
Enterprise Value (EV)
$-12.98M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Passage Bio, Inc. (PASG) | $12.88M | $-12.98M |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.86M | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $13.01M | $6.39M |
| Cytosorbents Corporation (CTSO)vs › | $12.60M | $34.52M |
| Dare Bioscience, Inc. (DARE)vs › | $12.56M | $6.70M |
| IRIDEX Corporation (IRIX)vs › | $12.37M | $11.71M |
| Optimi Health Corp. (OPTH)vs › | $13.56M | $7.98M |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | $5.85M |
| IN8bio, Inc. (INAB)vs › | $13.89M | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.89M | $4.06M |
Market Cap
$12.88M
Total Debt
$20.44M
Cash
$46.30M
Enterprise Value
$-12.98M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
